Our focus in the natural resources sector includes: oil, gas, renewable energy and clean technologies.

Red Cardinal Holdings, Inc. and their global partners are committed to providing a financial platform to international markets.

Red Cardinal Holdings, Inc.’s real estate group provides equity capital targeting residential and commercial projects.

We acquire full service, upscale, luxury properties, as well as prime development opportunities in the hospitality market.

We invest in high growth companies that sell clever, exciting products with high potential and sustainable gross margins.

Our primary focus is discovering, developing and investing in new medical technologies.

Medical Facilities & Medical Devices

Our primary focus is creating selfcontained, funded, managed medical and healthcare facilities.

A front burner issue for Red Cardinal is being able to utilize medical devices and biotechnology infrastructure sectors currently in place. Our goal is to build healthcare service facilities offering medical services to local demographics in need of urgent care.

Red Cardinal will take the lead role in medical care facility projects management, inclusive of placement of seasoned management and medical professional alike.

Medical Device Technology / Pharmaceuticals and Biotechnology

Point-Of-Care Medical Devices and future Pharmaceuticals and Biotechnology projects currently being developed for the use in everyday healthcare service are changing and improving day-to-day. However, the upward trend in spending in the development of such products have become cost prohibitive.


We are excited to participate with individual and upstart companies entering into the sector, bringing out of the box thinking and application methodology to find solutions at a fraction of the cost traditionally spent on bringing such products to market. We encourage development from entrepreneurial scientists who could build better and low cost  technology, enabling the necessary products a quicker introduction to the world market upon their FDA approval.

Red Cardinal will partner with internationally recognized medical device technology manufacturers, who may assume a role as investor, partner and distributor.